Key Dates

Related Announcements

PAR-22-231 - NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)

Issued by

National Institute of Nursing Research (NINR)

Purpose

The purpose of this notice is to inform applicants of a change to the Key Dates for PAR-22-231 “NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional).” The August Advisory Council Review cycle is being changed to October. Changes to the Funding Opportunity Announcement (FOA) are shown below.

Currently Reads:

Part 1. Overview Information

Key Dates:

Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Key Dates:

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

David L. Tilley, MPH, MS, CPH
National Institute of Nursing Research (NINR)
Telephone: 301-827-6014
Email: david.tilley@nih.gov